Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FAVUV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,255
Award facts
- Contract value 100% obligated
- $33,255.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,255.47 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Eliquis 5 mg tablets (60-count units). The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, employs firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group, based in Park Ridge, Illinois, has established itself as a significant supplier within the federal pharmaceutical supply chain since its 2001 SAM.gov registration. The company specializes in distributing branded and generic prescription medications, over-the-counter products, biologics, and medical consumables to Department of Defense healthcare sites. As a woman-owned small business, DMS has built a robust portfolio of delivery orders with the Defense Logistics Agency covering diverse pharmaceutical products ranging from specialty medications to vaccines and oncology treatments, demonstrating consistent capability in meeting federal procurement requirements for pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DB25FAVUV?
SPE2DB25FAVUV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FAVUV worth?
The government has obligated $33,255 on SPE2DB25FAVUV.
Is contract SPE2DB25FAVUV an order under another contract?
Yes. SPE2DB25FAVUV is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVUV competed?
The extent of competition for SPE2DB25FAVUV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award